Schroder Investment Management Group
BBH icon

Schroder Investment Management Group’s VanEck Biotech ETF BBH Stock Holding History

Schroder Investment Management Group’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,290
Closed -$114K – 1433
2013
Q4 		$114K Hold
1,290
– – ﹤0.01% 1279
2013
Q3 		$107K Buy
+1,290
New +$101K ﹤0.01% 1281

Other funds holding BBH

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
LFM
Lumina Fund Management New York $164M AUM 27.72% 1-Year Est. Return
AHS
Aspiriant Holdings S3 Los Angeles, California $233M AUM 3.13% 1-Year Est. Return

Schroder Investment Management Group's BBH Position: Q1 2014 in Review

Schroder Investment Management Group sold out of VanEck Biotech ETF (BBH) in Q1 2014, closing a stake of 1,290 shares — an estimated $114K sold.

Schroder Investment Management Group first reported a position in BBH in Q3 2013 and held it in 2 quarters. The position peaked at $114K in Q4 2013. 59 funds tracked by Wall St. Rank hold BBH as of Q1 2014.

  • Schroder Investment Management Group reported no remaining VanEck Biotech ETF position as of Q1 2014 after selling out during the quarter.
  • Schroder Investment Management Group sold 1,290 VanEck Biotech ETF shares in Q1 2014, an estimated $114K.
  • Schroder Investment Management Group first reported a position in VanEck Biotech ETF in Q3 2013 and held it in 2 quarters.
  • Schroder Investment Management Group's VanEck Biotech ETF position peaked at $114K in Q4 2013.
  • 59 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2014.

Based on Schroder Investment Management Group's 13F filing for Q1 2014, filed 15 May 2014.